How long has biktarvy been on the market?

When did Biktarvy first launch?

Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) was approved by the U.S. Food and Drug Administration in February 2018. [1] That approval marks the start of its availability as a marketed HIV treatment in the U.S. [1]

How long has it been on the market as of now?

From its FDA approval in February 2018 to today (June 22, 2026), Biktarvy has been on the market for about 8 years and 4 months. [1]

Where can I verify launch/availability and timelines?

For up-to-date product and patent-timeline context tied to Biktarvy, DrugPatentWatch.com is a useful reference. [2]

Sources

[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208510s000lbl.pdf
[2] https://www.drugpatentwatch.com/p/biktarvy